Supplemental material
Leukemia & Lymphoma
Volume 63, 2022 - Issue 2
Open access
5,400
Views
3
CrossRef citations to date
0
Altmetric
Original Articles
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial
Tara Cochranea Department of Haematology, Gold Coast University Hospital, Southport, Australia;b Griffiths University, Parkwood, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0002-2668-1399
, https://orcid.org/0000-0002-2668-1399
Alicia Enricoc Area Hematology, Hospital Italiano La Plata, Buenos Aires, Argentinahttps://orcid.org/0000-0002-1983-6145
, David Gomez-Almaguerd Hematology Service, Hospital Universitario, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Mexicohttps://orcid.org/0000-0002-0460-6427
, Evgueniy Hadjieve Department of Internal Medicine, Medical University Sofia, University Hospital Alexandrovska, Sofia, Bulgaria
, Ewa Lech-Marandaf Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
, Tamas Masszig Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungaryhttps://orcid.org/0000-0002-9038-302X
, Eugene Nikitinh Department of Hematology, Oncology and Chemotherapy, S. P. Botkin’s City Hospital, Moscow, Russiahttps://orcid.org/0000-0002-2490-1263
, Tadeusz Robaki Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Polandhttps://orcid.org/0000-0002-3411-6357
, Robert Weinkovej Wellington Blood & Cancer Centre, Capital & Coast District Health Board, Wellington, New Zealand;k Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealandhttps://orcid.org/0000-0003-3645-7988
, Shang-Ju Wul Department of Internal Medicine, Division of Haematology, National Taiwan University Hospital, Taipei City, Taiwan
, Kavita R. Sailm AbbVie, Inc., North Chicago, IL, USA
, John Peskom AbbVie, Inc., North Chicago, IL, USAhttps://orcid.org/0000-0002-7568-7762
, Madhavi Paim AbbVie, Inc., North Chicago, IL, USA
, Viktor Komlosin AbbVie Schweiz AG, Cham, Switzerland
& Mary Ann Andersono The Clinical Haematology Department of the Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia;p Division of Blood Cells and Blood Cancer, The Walter and Eliza Hall Institute, Parkville, Australiahttps://orcid.org/0000-0002-3515-0215
show all
Pages 304-314
|
Received 28 Jun 2021, Accepted 20 Sep 2021, Published online: 11 Oct 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.